Tryptamine Therapeutics Market Cap

Tryptamine Therapeutics has a market cap or net worth of 41.73 million as of June 25, 2025. Its market cap has increased by 23.93% in one year.

Market Cap

41.73M

Enterprise Value

38.91M

Revenue

1.33M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.03

Market Cap Chart

Since May 29, 2024, Tryptamine Therapeutics's market cap has increased from 38.06M to 41.73M, an increase of 9.63%. That is a compound annual growth rate of 8.94%.

Market Cap History

Date	Market Cap	% Change
Jun 25, 2025	41.73M	-13.97%
Dec 31, 2024	48.50M	27.43%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	115.46B
Pro Medicus	28.94B
Cochlear	19.27B
Sonic Healthcare	12.56B
Telix Pharmaceuticals	8.23B
Ramsay Health Care	8.19B
Ansell	4.35B
Regis Healthcare	2.30B

Market Cap Rankings